81 listed Pharmaceuticals companies ranked by total assets, from EDINET annual securities reports. Values in absolute JPY.
Also rank this industry: by Revenue · by Operating Income
| # | Company | Total Assets |
|---|---|---|
| 1 | Takeda Pharmaceutical Company Limited (4502) | ¥15,511,506,000,000 (≈ ¥15.51T) |
| 2 | Otsuka Holdings Co., Ltd. (4578) | ¥4,197,562,000,000 (≈ ¥4.20T) |
| 3 | DAIICHI SANKYO COMPANY, LIMITED (4568) | ¥3,996,285,000,000 (≈ ¥4.00T) |
| 4 | Astellas Pharma Inc. (4503) | ¥3,567,042,000,000 (≈ ¥3.57T) |
| 5 | Shionogi & Co.,Ltd. (4507) | ¥2,576,870,000,000 (≈ ¥2.58T) |
| 6 | CHUGAI PHARMACEUTICAL CO., LTD. (4519) | ¥2,468,595,000,000 (≈ ¥2.47T) |
| 7 | Eisai Co., Ltd. (4523) | ¥1,449,113,000,000 (≈ ¥1.45T) |
| 8 | Kyowa Kirin Co.,Ltd. (4151) | ¥1,107,860,000,000 (≈ ¥1.11T) |
| 9 | ONO PHARMACEUTICAL CO., LTD. (4528) | ¥1,106,515,000,000 (≈ ¥1.11T) |
| 10 | Sumitomo Pharma Co., Ltd. (4506) | ¥804,571,000,000 (≈ ¥0.80T) |
| 11 | TSUMURA & CO. (4540) | ¥592,766,000,000 (≈ ¥0.59T) |
| 12 | ROHTO PHARMACEUTICAL CO.,LTD. (4527) | ¥485,771,000,000 (≈ ¥0.49T) |
| 13 | TOWA PHARMACEUTICAL CO.,LTD. (4553) | ¥475,290,000,000 (≈ ¥0.48T) |
| 14 | SANTEN PHARMACEUTICAL CO.,LTD. (4536) | ¥423,033,000,000 (≈ ¥0.42T) |
| 15 | SAWAI GROUP HOLDINGS Co., Ltd. (4887) | ¥359,919,000,000 (≈ ¥0.36T) |
| 16 | Nippon Shinyaku Co.,Ltd. (4516) | ¥346,359,000,000 (≈ ¥0.35T) |
| 17 | KISSEI PHARMACEUTICAL CO.,LTD. (4547) | ¥275,086,000,000 (≈ ¥0.28T) |
| 18 | KYORIN Pharmaceutical Co., Ltd. (4569) | ¥195,455,000,000 (≈ ¥0.20T) |
| 19 | Mochida Pharmaceutical Co.,Ltd. (4534) | ¥182,720,000,000 (≈ ¥0.18T) |
| 20 | ZERIA PHARMCEUTICAL CO., LTD. (4559) | ¥179,697,949,000 (≈ ¥0.18T) |
| 21 | KAKEN PHARMACEUTIAL CO., LTD. (4521) | ¥178,217,000,000 (≈ ¥0.18T) |
| 22 | Nxera Pharma Co., Ltd. (4565) | ¥134,787,000,000 (≈ ¥0.13T) |
| 23 | ASKA Pharmaceutical Holdings CO., Ltd. (4886) | ¥112,379,000,000 (≈ ¥0.11T) |
| 24 | JCR Pharmaceuticals Co.,Ltd. (4552) | ¥109,236,000,000 (≈ ¥0.11T) |
| 25 | Fuji Pharma Co.,Ltd. (4554) | ¥93,405,000,000 (≈ ¥0.09T) |
| 26 | Fuso Pharmaceutical Industries,Ltd. (4538) | ¥90,323,000,000 (≈ ¥0.09T) |
| 27 | SEIKAGAKU CORPORATION (4548) | ¥86,344,000,000 (≈ ¥0.09T) |
| 28 | GNI Group Ltd. (2160) | ¥83,791,000,000 (≈ ¥0.08T) |
| 29 | PeptiDream Inc. (4587) | ¥77,033,187,000 (≈ ¥0.08T) |
| 30 | Daito Pharmaceutical Co., Ltd. (4577) | ¥73,291,000,000 (≈ ¥0.07T) |
| 31 | EIKEN CHEMICAL CO.,LTD. (4549) | ¥62,657,000,000 (≈ ¥0.06T) |
| 32 | NIPPON CHEMIPHAR CO., LTD. (4539) | ¥49,978,000,000 (≈ ¥0.05T) |
| 33 | TAUNS Laboratories, Inc. (197A) | ¥44,620,588,000 (≈ ¥0.04T) |
| 34 | KOA SHOJI HOLDINGS CO.,LTD. (9273) | ¥39,532,710,000 (≈ ¥0.04T) |
| 35 | YUKI GOSEI KOGYO CO.,LTD. (4531) | ¥25,730,000,000 (≈ ¥0.03T) |
| 36 | MIZUHO MEDY CO.,LTD. (4595) | ¥22,375,000,000 (≈ ¥0.02T) |
| 37 | MORISHITA JINTAN CO.,LTD. (4524) | ¥18,623,000,000 (≈ ¥0.02T) |
| 38 | HEALIOS K.K. (4593) | ¥17,054,000,000 (≈ ¥0.02T) |
| 39 | WAKAMOTO PHARMACEUTICAL CO.,LTD. (4512) | ¥16,499,607,000 (≈ ¥0.02T) |
| 40 | SanBio Company Limited (4592) | ¥15,621,539,000 (≈ ¥0.02T) |
| 41 | TAIKO PHARMACEUTICAL CO., LTD. (4574) | ¥12,270,000,000 (≈ ¥0.01T) |
| 42 | RaQualia Pharma Inc. (4579) | ¥10,514,193,000 (≈ ¥0.01T) |
| 43 | Kohjin Bio Co., Ltd. (177A) | ¥8,904,397,000 |
| 44 | StemCell Institute Inc. (7096) | ¥8,124,841,000 |
| 45 | Ｈｅａｒｔｓｅｅｄ株式会社 (219A) | ¥7,675,749,000 |
| 46 | MUROMACHI CHEMICALS INC. (4885) | ¥6,352,689,000 |
| 47 | Kidswell Bio Corporation (4584) | ¥6,088,396,000 |
| 48 | StemRIM Inc. (4599) | ¥5,909,230,000 |
| 49 | Nano Holdings, Inc. (4571) | ¥5,906,339,000 |
| 50 | AnGes, Inc. (4563) | ¥5,405,983,000 |
| 51 | CHUKYOIYAKUHIN CO.,LTD. (4558) | ¥5,285,285,000 |
| 52 | Cuorips Inc. (4894) | ¥5,123,122,000 |
| 53 | イノバセル株式会社 (504A) | ¥5,092,561,000 |
| 54 | J-Pharma Co.,Ltd. (520A) | ¥4,761,406,000 |
| 55 | Oncolys BioPharma Inc. (4588) | ¥4,555,879,000 |
| 56 | ステラファーマ株式会社 (4888) | ¥4,486,694,000 |
| 57 | 株式会社サイフューズ (4892) | ¥4,266,026,000 |
| 58 | ノイルイミューン・バイオテック株式会社 (4893) | ¥4,011,579,000 |
| 59 | SymBio Pharmaceuticals Limited (4582) | ¥3,867,316,000 |
| 60 | Renascience Inc. (4889) | ¥3,503,263,000 |
| 61 | 株式会社ＰＲＩＳＭ ＢｉｏＬａｂ (206A) | ¥3,085,692,000 |
| 62 | RIBOMIC Inc. (4591) | ¥2,976,215,000 |
| 63 | Modalis Therapeutics Corporation (4883) | ¥2,964,248,000 |
| 64 | K Pharma,Inc. (4896) | ¥2,939,220,000 |
| 65 | TMS Co., Ltd (4891) | ¥2,865,277,000 |
| 66 | Chordia Therapeutics,Inc (190A) | ¥2,681,349,000 |
| 67 | BrightPath Biotherapeutics Co., Ltd. (4594) | ¥2,604,864,000 |
| 68 | OncoTherapy Science, Inc. (4564) | ¥2,359,354,000 |
| 69 | D.Western Therapeutics Institute, Inc. (4576) | ¥2,169,461,000 |
| 70 | 株式会社メドレックス (4586) | ¥2,157,533,000 |
| 71 | Immuno-Biological Laboratories Co., Ltd. (4570) | ¥2,155,121,000 |
| 72 | ソレイジア・ファーマ株式会社 (4597) | ¥2,145,000,000 |
| 73 | Kringle Pharma,Inc. (4884) | ¥2,079,363,000 |
| 74 | 株式会社ファンペップ (4881) | ¥1,980,860,000 |
| 75 | Kubota Pharmaceutical Holdings Co., Ltd. (4596) | ¥1,979,457,000 |
| 76 | 株式会社Ｖｅｒｉｔａｓ Ｉｎ Ｓｉｌｉｃｏ (130A) | ¥1,884,912,000 |
| 77 | CanBas Co.,Ltd. (4575) | ¥1,776,754,000 |
| 78 | Chiome Bioscience Inc. (4583) | ¥1,727,504,000 |
| 79 | Perseus Proteomics Inc. (4882) | ¥1,623,541,000 |
| 80 | Carna Biosciences, Inc. (4572) | ¥1,229,648,000 |
| 81 | Delta-Fly Pharma, Inc. (4598) | ¥246,670,000 |
Free 5-year dataset on Kaggle / Hugging Face; full 3,600-company pack on RapidAPI.
Ranking size proxied by revenue where market cap is unavailable. Not investment advice.